TY - JOUR
T1 - Learning from post-COVID-19 condition for epidemic preparedness
T2 - a variable catalogue for future post-acute infection syndromes
AU - Górska, Anna
AU - Canziani, Lorenzo Maria
AU - Rinaldi, Eugenia
AU - Pana, Zoi D.
AU - Beale, Sarah
AU - Bai, Francesca
AU - Boxma-de Klerk, Bianca M.
AU - de Bruijn, Simeon
AU - Donà, Daniele
AU - Ekkelenkamp, Miquel B.
AU - Incardona, Francesca
AU - Mallon, Patrick
AU - Marchetti, Giulia C.
AU - Puhan, Milo
AU - Riva, Agostino
AU - Simensen, Victoria C.
AU - Vaillant, Michel
AU - van der Zalm, Marieke M.
AU - van Kuijk, Sander M.J.
AU - Wingerden, Sophie van
AU - Judd, Ali
AU - Tacconelli, Evelina
AU - Peñalvo, José L.
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2025/3
Y1 - 2025/3
N2 - Scope: The emergence of post-COVID-19 condition (PCC) after SARS-CoV-2 infection underscores the critical need for preparedness in addressing future post-acute infection syndromes (PAIS), particularly those linked to epidemic outbreaks. The lack of standardized clinical and epidemiological data during the COVID-19 pandemic has significantly hindered timely diagnosis and effective treatment of PCC, highlighting the necessity of pre-emptively standardizing data collection in clinical studies to better define and manage future PAIS. In response, the Cohort Coordination Board, a consortium of European-funded COVID-19 research projects, has reviewed data from PCC studies conducted by its members. This paper leverages the Cohort Coordination Board's expertise to propose a standardized catalogue of variables, informed by the lessons learned during the pandemic, intended for immediate use in the design of future observational studies and clinical trials for emerging infections of epidemic potential. Recommendations: The early implementation of standardized data collection, facilitated by the PAIS data catalogue, is essential for accelerating the identification and management of PAIS in future epidemics. This approach will enable more precise syndrome definitions, expedite diagnostic processes, and optimize treatment strategies, while also supporting long-term follow-up of affected individuals. The availability of harmonized data collection protocols will enhance preparedness across European and international cohort studies, and trials enabling a prompt and coordinated response, as well as more efficient resource allocation, in the event of emerging infections and associated PAIS.
AB - Scope: The emergence of post-COVID-19 condition (PCC) after SARS-CoV-2 infection underscores the critical need for preparedness in addressing future post-acute infection syndromes (PAIS), particularly those linked to epidemic outbreaks. The lack of standardized clinical and epidemiological data during the COVID-19 pandemic has significantly hindered timely diagnosis and effective treatment of PCC, highlighting the necessity of pre-emptively standardizing data collection in clinical studies to better define and manage future PAIS. In response, the Cohort Coordination Board, a consortium of European-funded COVID-19 research projects, has reviewed data from PCC studies conducted by its members. This paper leverages the Cohort Coordination Board's expertise to propose a standardized catalogue of variables, informed by the lessons learned during the pandemic, intended for immediate use in the design of future observational studies and clinical trials for emerging infections of epidemic potential. Recommendations: The early implementation of standardized data collection, facilitated by the PAIS data catalogue, is essential for accelerating the identification and management of PAIS in future epidemics. This approach will enable more precise syndrome definitions, expedite diagnostic processes, and optimize treatment strategies, while also supporting long-term follow-up of affected individuals. The availability of harmonized data collection protocols will enhance preparedness across European and international cohort studies, and trials enabling a prompt and coordinated response, as well as more efficient resource allocation, in the event of emerging infections and associated PAIS.
KW - eCRF
KW - Long COVID-19
KW - Pandemic preparedness
KW - Post-acute infection syndrome
KW - Post-COVID-19 condition
KW - Prospective clinical studies
KW - Standardization
UR - https://www.scopus.com/pages/publications/85213534033
U2 - 10.1016/j.cmi.2024.12.001
DO - 10.1016/j.cmi.2024.12.001
M3 - Short survey
C2 - 39662824
AN - SCOPUS:85213534033
SN - 1198-743X
VL - 31
SP - 380
EP - 388
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
IS - 3
M1 - doi.org/10.1016/j.cmi.2024.12.001
ER -